Adrenomedullin - Physiological regulator of the cardiovascular system or biochemical curiosity?

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 1, 1997, Pages 80-87

  Kitamura, Kazuo ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; VASOACTIVE AGENT;

CARDIOVASCULAR SYSTEM; HUMAN; PRIORITY JOURNAL; REVIEW; VASODILATATION;

ADRENOMEDULLIN; AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR PHYSIOLOGY; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE BIOSYNTHESIS; PEPTIDES; RATS;

EID: 0031056235     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199701000-00015     Document Type: Review

References (89)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T: Adrenomedullin. A novel hypotensive peptide isolated from human pheochromocytomoa. Biochem Biophys Res Commun 1993, 192:553-560.
2. Sakata J, Shimokubo T, Kitamura K, Nakamura S, Kangawa K, Matsuo H, Eto T: Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993, 195:921-927.
3. Kitamura K, Kangawa K, Kojima M, Ichiki Y, Matsuo H Eto T: Complete amino acid sequence of porcine adrenomedullin and cloning of cDNA encoding its precursor. FEBS Lett 1994, 338:306-310.
4. Eguchi S, Hirata Y, Iwasaki H, Sato K, Watanabe TX, Inui T, Najajima K, Sakakibara S, Marumo F: Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide in cultured rat vascular smooth muscle cells. Endocrinology 1994, 135:2454-2458.
5. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T: Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993, 194:720-725.
6. Ishimitsu T, Kojima M, Kangawa K, Hino J, Matsuoka H, Kitamura K, Eto T, Matsuo H: Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994, 203:631-639.
7. Washimme H, Asada Y, Kitamura K, Ichiki Y, Hara S, Yamamoto Y, Kangawa K, Sumiyoshi A, Eto T: Immunohistochemical identification of adrenomedullin in human, rat and porcine tissue. Histochem Cell Biol 1995, 103:251-254.
8. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994, 338:6-10.
9. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Abe K, Miura Y, Hayashi Y, Sasano H, Mouri T: Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995, 80:1750-1752.
10. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima M, Yamamoto S, Kangawa K, Matsuo H, Eto T, Yamashita H: Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995, 202:37-40.
11. Jougasaki M, Wei C-M, Heubleim DM, Sandberg SM, Burnett JC Jr: Immunohistochemical localization of adrenomedullin in canine heart and aorta. Peptides 1995, 6:773-775.
12. Jougasaki M, Wei C-M, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC Jr: Renal localization and actions of adrenomedullin. A natriuretic peptide. Am J Physiol 1995, 268:657-663. AM exists in renal glomurular and tubular cells and is a potent natriuretic peptide that might play an important role in the regulation of sodium excretion.
13. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H: Endothelial cells activeklky synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994, 201:1160-1166.
14. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H: Production and secretion of adrenomedullin from vascular smooth muscle cells. Augmented production by tumor necrosis factor-alpha Biochem Biophys Res Commun 1994, 203:719-726.
15. Ishizaka Y, Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T: Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Rest Commun 1994, 200:642-646.
16. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe TX, Nakajima K, Sakakibara S, Maruno F: Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 1994, 340:226-230.
17. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, Eto T, Kangawa K, Matsuo H: Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and calcium mobilization, in bovine aortic endothelial cells. J Biol Chem 1995, 270:4412-4417.
18. Kato J, Kitamura K, Kangawa K, Eto T: Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995, 289:383-385.
19. Sugo S, Minamino N,m Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H: Interleukin-1, tumor necrosis factor and lipopolysaccaride additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995, 207:25-32.
20. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H: Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett 1995, 369:311-314. Various substances influencing VSMC function also regulate AM production in VSMC, suggesting a complex regulation system of AM production in VSMC.
21. Minamino N, Shoji H, Sugo S, Kangawa K, Matsuo H: Adrenocortical steriods, thyroid hormones and retinoic acid augment the production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995, 211:686-693.
22. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F: Expression of adrenomedullin in normal human lung and pulmonary tumors. Endocrinology 1995, 136:4099-4105. AM is synthesized by several cell populations of the normal lung, tumour cell lines of pulmonary origin, and tumour specimens. AM may play a broad role in respiratorty homeostasis and lung carcinogenesis.
23. Kanazawa H, Kurihara N, Hirata K, Kudoh S, Kawaguchi T, Takeda T: Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator. Biochem Biophys Res Commun 1994, 205:251-254.
24. Kanazawa H, Kawaguchi T, Fujii T, Kudoh S, Hirata K, Kurihara N, Takeda T: Comparison of bronchodilator responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide. Life Sci 1995, 57:PL241-PL245.
25. Ishiyama Y, Kitamura K, Ichiki Y, Nakamura S, Kida O, Kangawa K, Eto T: Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin in rats. Eur J Pharmacol 1993, 241:271-273.
26. Feng CJ, Kang B, Kaye AD, Kadowitz PJ, Nossaman BD: L-NAME modulates responses to adrenomedullin in the hindquarters vascular bed of the rat. Life Sci 1994, 55:PL43-PL438.
27. Santiago JA, Garrison E, Purnell WL, Smith RE, Champion HC, Coy DH, Murphy WA, Kadowitz PJ: Comparison of responses to adrenomedullin and adrenomedullin analogs in the mesenteric vascular bed of the cat. Eur J Pharmacol 10995, 272:115-118.
28. Matsunaga K, Iwasaki T, Yonetani Y, Kitamura K, Eto T, Kangawa K, Matsuo H: Nitric oxide-dependent hypotensive effects of adrenomedullin in rats. Drug Dev Res 1996, 37:55-60.
29. Gardiner SM, Kemp PA, March JE, Bennett T: Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol 1995, 114:584-591.
30. Parkes DG: Cardiovascular actions of adrenomedullin in conscious sheep. Am J Physiol 1995, 268:2574-2578. First study to report the detailed cardiovascular actions of AM in conscious animals. Data suggest that AM might be a novel peptide involved in regulation of the cardiovascular system in mammals.
31. Fukahara M, Tsuchihashi T, Abe I, Fujishima M: Cardiovascular and neurohormal effects of intravenous adrenomedullin in conscious rabbits. Am J Physiol 1995, 269:1289-1293.
32. Nossaman BD, Feng CJ, Kaye AD, DeWitt B, Coy DH, Murphy WA, Kadowitz PJ: Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats. Am J Physiol 1996, 270:782-789.
33. He H, Bessho H, Fujisawa Y, Horiuchi K, Tomohiro A, Kita T, Aki Y, Kimura S, Tamaki T, Abe Y: Effects of a synthetic rat adrenomedullin on regional hemodynamics in rats. Eur J Pharmacol 1995, 273:209-214. An intravenous infusion of AM to Sprague-Dawley rats and spontaneously hypertensive rats resulted in significant increases of the flow rates in the lungs, heart, spleen, kidneys, adrenal glands and small intestine of both strains of rats. AM predominantly increased the flow rates in organs in which AM gene was highly expressed.
34. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T: Inhibitioon of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995, 25:1185-1190.
35. Tian Q, Zhao DY, Tan YT, Zhao QH, Li JX, Qiu LW, Song CN, Gong CN, Yang J, Lippton H et al.: Vasodilator efect of human adrenomedullin (13-52) on hypertensive rats. Can J Pharmacol 1995, 73:1065-1069.
36. Ikeda U, Kanbe T, Shimada K: Adrenomedullin increases inducible nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin-1. Hypertension 1996, 27:1240-1243.
37. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, Takeda T: Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circulation Res 1995, 77:660-664. AM inhibits the migration of smooth muscle cells stimulated with foetal calf serum and platelet derived growth factor, probably through a cAMP-dependent process. AM might play a role as a local anti-migration factor in some pathophysiological states.
38. Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Takeda T, Yoshikawa J: Adrenomedullin as a novel antiproliferative factor in vascular smooth muscle cells. J Hypertens 1996, 14:209-213.
39. Sato A, Autelitano DJ: Adrenomedullin induces expression of c-fos and AP-1 activity in rat vascular smooth muscle cells and cardiomyocytes. Biochem Biophys Res Commun. 1995, 217:211-216.
40. Ebara T, Miura K, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H: Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994, 263:69-73.
41. Haynes Jm, Cooper ME: Adrenomedullin and calcitonin gene-related peptide in the rat isolated kidney and in the anaesthetised rat. In-vitro and in-vivo effects. Eur J Pharmacol 1995, 280:91-94.
42. Miura K, Ebara T, Okumura M, Matsuura T, Kim S, Yukimura T, Iwao H: Attenuation of adrenomedullin-induced renal vasodilatation by N-nitro L-arginine but not glibenclamide. Br J Pharmacol 1995, 115:917-924.
43. Seguchi H, Nishimura J, Kobayashi S, Kumazawa J, Kanaide H: Autocrine regulation of the renal arterial tone by adrenomedullin. Biochem Biophys Res Commun 1995, 215:619-625.
44. Majid DSA, Kadowitz PJ, Coy DH, Navar LG: Renal responses to intra-arterial administration of adrenmedullin in dogs. Am J Physiol 1996, 270:200-205.
45. Vari RC, Adkins SD, Samson WK: Renal effects of adrenomedullin in the rat. Proc Soc Exp Biol Med 1996, 211:178-183.
46. Hirata Y, Hayakawa H, Suzuki Y, Suzuki E, Ikenouchi H, Kohmoto O, Kimura K, Kitamura K, Eto T, Kangawa K, Matsuo H, Omata M: Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995, 25:790-797.
47. Mazzocchi G, Rebuffat P, Gottardo G, Nussdorfer GG: Adrenomedullin and calcitonin gene-related peptide inhibit aldosterone secretion in rats, acting via a common receptor. Life Sci 1996, 58:839-844.
48. Yamaguchi T, Baba K, Soi Y, Yano K: Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zone glomerulosa cells. Life Sci 1995, 56:379-387.
49. Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T: Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat. Hypertension 1996, 28:308-314. AM injected subcutaneously in Sprague-Dawley rats, significantly inhibited sodium-deficient diet - and bilateral nephrectomy - stimulated aldosterone production, but it did not affect plasma corticosterone concentration.
50. Samson WK, Murphy T, Schell DA: A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 1995, 136:2349-2352.
51. Parkes DG, May CN: ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep. J Neuroendocrinol 1995, 7:923-929.
52. Murphy TC, Samson WK: The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology 1995, 136:2459-2463. AM was found to be antidipsogenic. Cerebroventricular injection of AM resulted in a dose-related diminution of water drinking in response to subsequent central administration of angiotensin II.
53. Martinez A, Weaver C, Lopez J, Bhathena SJ, Elsasser TH, Miller MJ, Moody TW, Unsworth EJ, Cuttitta F: Regulation of insulin secretion and blood glucose metabolism by adrenomedullin. Endocrinology 1996, 137:2626-2632. AM inhibits insulin secretion in a dose-dependent manner in isolated rat islets. Further, the monoclonal antibody, which neutralizes AM bioactivity, was able to increase insulin release. AM is a possible new factor of the insulin regulatory system.
54. Mulder H, Ahren B, Karlsson S, Sundler F: Adrenomedullin. Localization in the gastrointestinal tract and effects on insulin secretion. Regul Pept 1996, 62:107-112.
55. Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, Ghatei MA, Bloom SR: An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995, 136:2127-2134.
56. Kapas S, Catt KJ, Clark AJL: Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 1995, 270:25344-25347. A cDNA clone encoding AM receptor was isolated and sequenced. AM receptor was an orphan receptor from rat lung. It has a general structural resemblance to other members of the G protein-linked superfamily. When expressed in COS-7 cells, this receptor mediates a cAMP response to AM.
57. Kapas S, Clark AJL: Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem Biophys Res Commun 1995, 217:832-838.
58. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y: A cDNA encoding the calcitonin gene-related peptide type 1 receptor. Human CGRP Receptor 1996, 271:11325-11329.
59. Withers DJ, Coppock HA, Seufferlein T, Smith DM, Bllom SR, Rozengurt E: Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett 1996, 378:83-87.
60. Kureishi Y, Kobayashi S, Nishimura J, Nakano T, Kanaide H: Adrenomedullin decreases both cytosolic calcium concentration and calcium-sensitivity in pig coronary arterial smooth muscle. Biochem Biophys Res Commun 1995, 212:572-579.
61. Seguchi H, Nishimura J, Kobatashi S, Kumazawa J, Kanaide H: Autocrine regulacion of the renal arterial tone by adrenomedullin. Biochem Biophys Res Commun 1995, 215:619-625.
62. Houchi H, Yoshizumi M, Shono M, Ishimura Y, Ohuchi T, Oka M: Adrenomedullin stimulates calcium efflux from adrenal chromaffin cells in culture. Possible involvement of an Na/Ca exchange mechanism. Life Sci 1996, 58:PL35-PL40.
63. Kuwasako K, Kitamura K, Ichiki Y, Kato J, Kangawa K, Matsuo H, Eto T: Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla. Biochem Biophys Res Commun 1995, 211:694-699. Isolation and determination of human PAMP from pheochromocytoma, which was deduced by cDNA analyses. It has been further demonstrated that biosynthesis or metabolism of PAMP in pheochromocytoma may be different from that of normal adrenal medulla.
64. Kitamura KJ, Kangawa K, Ishiyama Y, Washimine H, Ichiki Y, Kawamoto M, Minamino N, Matsuo H, Eto T: Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP). FEBS Lett 1994, 351:35-37.
65. Washimine H, Kitamura K, Ichiki Y, Yamamoto Y, Kangawa K, Matsuo H, Eto T: Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine. Biochem Biophys Res Commun 1994, 20:1081-1087.
66. Katoh F, Kitamura K, Niina H, Yamamoto R, Washimine H, Kangawa K, Yamamoto Y, Kobayashi H, Eto T, Wada A: Proadrenomedullin N-terminal 20 peptide (PAMP), an endogenous anticholinergic peptide. Its exocytotic secretion and inhibition of catecholamine secretion in adrenal medulla. J Neurochem 1995, 64:459-461.
67. Fujita T: Hypertensive action of proadrenomedullin N-terminal 20 peptide [Abstract]. COE International Symposium. The 10th Japanese Symposium on ANP. Osaka. November 1995.
68. 2-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings. J Clin Invest 1995, 96:1672-1676. PAMP and AM, which are derived from the same gene, exhibit different hypotensive mechanisms. PAMP inhibits neural transmission at peripheral sympathetic nerve ending, although AM directly dilates vascular smooth muscle.
69. Kitamura K, Ichiki Y, Tanaka M, Kawamoto M, Emura J, Sakakibara S, Kangawa K, Matsuo H, Eto T: Immunoreactive adrenomedullin in human plasma. FEBS Lett 1994, 341:288-290.
70. Tanaka M, Kitamura K, Ishizaka Y, Ishiyama, Y, Kato J, Kangawa K, Eto T: Plasma adrenomedullin in various diseases and exercise-induced change in adrenomedullin in healthy subjects. Internal Med 1995, 34:728-733. Plasma AM concentration is increased in the patients with cardiovascular disease including congestive heart failure, essential hypertension and renal diseases.
71. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994, 94:2158-2161.
72. Kohno M, Hanehira T, Kano H, Horio T, Yokokawa K, Ikeda M, Minami M, Yasunari K, Yoshikawa J: Plasma adrenomedullin concentrations in essencial hypertension. Hypertension 1996, 27:102-107.
73. Kato J, Kitamura K, Kuwasako K, Tanaka M, Ishiyama Y, Shimokubo T, Ichiki Y, Nakamura S, Kangawa K, Eto T: Plasma adrenomedullin in patients with primary aldosteronism. Am Hypertension 1996, 8:997-1000.
74. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T: Alternation in tissue concentration and gene expression of adrenomedullin in spontaneously hypertensive rats. Pathophysiology 1995, 2:223-226.
75. Inatsu H, Sakata J, Shimokubo T, Kitani M, Nishizono M, Washimine H, Kitamura K, Kangawa K, Matsuo H, Eto T: Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat. Biochem Mol Biol Int 1996, 38:365-372.
76. Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takemiya M, Kangawa K, Matsuo H, Eto T, Omae T, Matsuoka H: Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994, 24:600-604.
77. Eto T, Washimine H, Kato J, Kitamura K, Yamamoto Y: Adrenomedullin and proadrenomedullin N-terminal 20 peptide in impaired renal function. Kidney Int 1996, 49:3148-3149.
78. Sato K, Hirata Y, Imai T, Iwashina M, Marumo F: Characterization of immunoreactive adrenomedullin in human plasma and urine. Life Sci 1995, 57:189-194.
79. Washimine H, Yamamoto Y, Kitamura K, Ichiki Y, Kangawa K, Matsuo H, Eto T: Plasma concentration of human adrenomedullin in patients on hemodialysis. Clin Nephrol 1995, 44:389-393.
80. Kobayashi K, Kitamura K, Etoh T, Nagatomo Y, Takenaga M, Ishikawa T, Imamura T, Koiwaya Y, Eto T: Increased plasma adrenomedullin levels in chronic congestive heart failure. Amer Heart J 1996, 131:994-998.
81. Jougasaki M, Wei C-M, McKinley LJ, Burnett JC Jr: Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1996, 92:286-289.
82. Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, Hanada Y, Nagatomo Y, Takenaga M, Ishikawa T et al.: Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996, 131:676-680.
83. Jougasaki M, Rodeheffer RJ, Redfield MM, Yamamoto K, Wei CM, McKinley LJ, Burnett JC Jr: Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 1996, 97:2370-2376. Circulating AM is increased in human congestive heart failure. Further study indicates the possibility that the failing ventricle contributes to the increased concentration of AM in patients with congestive heart failure.
84. Nishikimi T, Saito Y, Kitamura K, Ishimitsu T, Eto T, Kangawa K, Matsuo H, Omae T, Matsuoka H: Increased plasma levels of adrenomedullin in patients with heart failure. JACC 1995, 15:1424-1431.
85. Kato J, Kobayashi K. Etoh T, Tanaka M, Kitamura K, Imamura T, Koiwaya Y, Kangawa K, Eto T: Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996, 81:180-183.
86. Taniyama M, Kitamura K, Ban Y, Eto T, Katagami T: Elevated plasma adrenomedullin level in hyperthyroidism. Eur J Invest 1996, 26: 454-456.
87. Wang XK, Yue TL, Barone FC, White RF, Clarke RK, Willette RN, Sulpizio AC, Aiyar NV, Ruffolo RR Jr, Feuerstein GZ: Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci USA 1995, 92:11480-11484.
88. Shoji H, Minamino N, Kangawa K, Matsuo H: Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 1995, 215:531-537. A marked increase in AM concentration was observed in rat plasma collected after intravenous infusion of lipopolysaccaride, suggesting that actively produced AM in vascular cells participates as a vasodilator in blood pressure regulation during endotoxin (septic) shock.
89. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F: Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996, 81:1449-1453. Plasma AM concentrations of immunoreactive AM in patients with sepsis were extremely elevated compared with those of normal subjects. Increased endogenous AM may be involved in the mechanism of cardiovascular abnormalities associated with sepsis.